call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Perinatal Infections Market
Inquire Before Buying Request for Sample

Perinatal Infections Market

Home Healthcare And Pharmaceutical Perinatal Infections Market

Perinatal Infections Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Infection (Cytomegalovirus Infection, Enterovirus Infection, Genital Herpes, Gonorrhoea, Human Immunodeficiency Virus, Others); By Diagnosis (Maternal Test, Neonatal Test, Others); By Treatment (Antibiotics, Antiviral, Antiretroviral, Others); By Route of Administration (Oral, Parenteral, Others); By End User (Hospitals, Homecare, Specialty Clinics, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: April 2023
  • Report ID: BWC23333
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing cases of HIV and increasing incidence of perinatal infections are expected to boost the growth of global perinatal infections market during the forecast period between 2023 and 2029

Global Perinatal Infections Market - Industry Trends & Forecast Report, 2029

Global perinatal infections market size is projected to grow at a CAGR of 7.30% during the forecast period between 2023 and 2029. Major growth factors for the global perinatal infections market include a high birth rate and rising annual birth rate, as well as unhygienic conditions around people giving birth, especially in underdeveloped nations. The increasing number of premature deliveries is emerging as the major cause of perinatal infections, which is anticipated to drive market growth during the forecast period.

Global Perinatal Infections Market – Overview

Perinatal infections are infections that can be passed from the person giving birth to the newborn during pregnancy, childbirth, or the first few hours following birth. Because newborns, especially those born preterm, have a limited capacity for symptom expression, even little variations from the norm should be taken as a sign of bacterial illness. Infections like the flu, vaginal yeast infections, dermatitis, herpes, uterine infections, group B streptococcus (GBS), bacterial vaginosis (BV), and listeria are frequently seen during pregnancy.

Global Perinatal Infections Market

Growth Drivers

Increasing Cases of Perinatal Infections and Neonatal Mortality

According to research published by the National Center for Biotechnology Information, 10.7% of all maternal fatalities worldwide are caused by direct maternal infections. 98% of neonatal deaths occur in low- and middle-income countries (LMIC), with South Asia and sub-Saharan Africa, accounting for 79% of these deaths. Over one-third of neonatal deaths occur during the first day of life and around two-thirds within the first week. Neonatal sepsis is a significant contributor to infant morbidity and mortality, accounting for at least one-third of those fatalities. Despite a global decrease in newborn mortality of 20 fatalities per 1000 live births between 1990 and 2019, the burden of infection-related neonatal mortality did not considerably decrease over that time, which is expected to fuel the growth of global perinatal infections market during the forecast period.

Restraints

Lack of Skilled Professionals

The expansion of the global perinatal infections market during the forecast period may be restrained by a lack of skilled professionals who are able to treat patients with the proper treatments.

Impact of COVID-19 on Global Perinatal Infections Market

According to research published in the National Center for Biotechnology Information, no specific or convincing evidence exists to support the notion that SARS-CoV and MERS-CoV are vertically transmitted. Similarly, there is not enough evidence at this time to demonstrate that COVID-19 is transmitted vertically. However, a newborn delivered to a pregnant person who had COVID-19 was said to have higher IgM antibody levels to SARS-CoV-2 in blood two hours after delivery, indicating that COVID-19 may have the potential for vertical transmission. This resulted in significant growth in the overall global perinatal infections market.

Global Perinatal Infections Market

Segmental Coverage

Global Perinatal Infections Market – By Infection

Based on infection, the global perinatal infections market is divided into cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, and other segments. The human immunodeficiency virus (HIV) segment accounts for the highest market share. The HIV transmission from mother to newborn is a worldwide issue. About 7% to 40% of babies with HIV-positive mothers develop the disease. These newborns have a dismal prognosis, as the majority suffer diseases that advance quickly and early in life.

Global Perinatal Infections Market – By Diagnosis

Based on the diagnosis, the global perinatal infections market is segmented into the maternal test, neonatal tests, and others. The maternal test accounts for the highest share of the global perinatal infections market. Little to no immunity exists in the embryo and fetus, therefore they are immune and dependent on their mother. Numerous diseases have the ability to pass through the placenta and infect the fetus. Because bacteria that cause mild illnesses in pregnant people can be extremely hazardous to the growing embryo or baby, pregnant people frequently undergo diagnosis to detect any form of infection.

Global Perinatal Infections Market – By Treatment

Based on treatment, the global perinatal infections market is segmented into antibiotics, antiviral, antiretroviral, and others. The antibiotics treatment accounts for the highest market share. Prompt empiric antibiotic therapy with medications like ampicillin and gentamicin or ampicillin and cefotaxime is the main treatment for suspected bacterial infection in the newborn.

Global Perinatal Infections Market – By Route of Administration

Based on the route of administration, the global perinatal infections market is segmented into oral, parenteral, and others. The parenteral route of administration holds the highest share of the global perinatal infections market. Parenteral medication delivery has a quicker and more controlled bioavailability. Parenteral drug delivery avoids interference from liver metabolism for the medicine. The low concentration of medicine required by this route and the lack of risk of drug degradation by digestive fluids all help to fuel the market expansion for this route.

Perinatal Infections Market Size

Global Perinatal Infections Market – By End User

Based on end user, global perinatal infections market is segmented into hospitals, homecare, specialty clinics, and others. The hospital segment accounts for the highest market share, as hospitals are considered the safest settings for delivery. According to the National Academics, a vast majority of Americans, around 98.4%, give birth in a hospital, which contributes to the segment’s growth. However, homecare and specialty clinics are also projected to register a high growth rate during the forecast period owing to the growing number of pregnant people opting to give birth outside of hospitals, either at home or in specialized birthing facilities known as birth centers.

Global Perinatal Infections Market – By Region

The in-depth research report on the global perinatal infections market covers the markets in various countries across five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Middle East and Africa region dominates the global perinatal infections market. According to a research published by National Center for Biotechnology Information, 98% of newborn deaths occur in low- and middle-income countries (LMIC), 79% of which take place in South Asia and sub-Saharan Africa, among which at least one-third of those fatalities are connected to infection and Neonatal sepsis is a significant contributor to infant morbidity and mortality.

Competitive Landscape

Major players operating in the global Perinatal Infections market include Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, Hologic Inc., Gilead Sciences, Inc., Emcure Pharmaceuticals Limited., Cipla Inc., Hetero, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd, Sanofi, Novartis AG, and Sun Pharmaceutical Industries Ltd.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD million

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Infection, Diagnosis, Treatment, Route of Administration, End User, Region

Key Players

Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, Hologic Inc., Gilead Sciences, Inc., Emcure Pharmaceuticals Limited., Cipla Inc., Hetero, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd

 

 

By Infection

  • Cytomegalovirus Infection

  • Enterovirus Infection

  • Genital Herpes

  • Gonorrhoea

  • Human Immunodeficiency Virus

  • Others

By Diagnosis

  • Maternal Test

  • Neonatal Test

  • Others

By Treatment

  • Antibiotics

  • Antiviral

  • Antiretroviral

  • Others

By Route of Administration

  • Oral

  • Parenteral

  • Others

By End User

  • Hospitals

  • Homecare

  • Specialty Clinics

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Infection Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Perinatal Infections Market Insights
    1. Industry Value Chain Analysis
      1. DROC Analysis
      2. Growth Drivers
        1. Increased Cases of HIV
        2. Increasing Incidence of Perinatal Infections
      3. Restraints
        1. Lack of skilled professionals
      4. Opportunities
        1. Increasing Demand for Retail Pharmacies
      5. Challenges
        1. High Cost Involved in Treatment
    2. Technological Advancement/Recent Developments
    3. Regulatory Framework
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Perinatal Infections Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Infection
        1. Cytomegalovirus Infection
        2. Enterovirus Infection
        3. Genital Herpes
        4. Gonorrhoea
        5. Human Immunodeficiency Virus
        6. Others
      2. By Diagnosis
        1. Maternal Test
        2. Neonatal Test
        3. Others
      3. By Treatment
        1. Antibiotics
        2. Antiviral
        3. Antiretroviral
        4. Others
      4. By Route of Administration
        1. Oral
        2. Parenteral
        3. Others
      5. By End User
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
      6. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Perinatal Infections Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
      6. By Country
        1. United States
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        2. Canada
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
  6. Europe Perinatal Infections Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
      6. By Country
        1. Germany
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        2. UK
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        3. Italy
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        4. France
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        5. Spain
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        6. The Netherlands
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        7. Rest of Europe
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
  7. Asia-Pacific Perinatal Infections Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
      6. By Country
        1. China
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        2. India
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        3. Japan
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        4. South Korea
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        5. Australia & New Zealand
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        6. Indonesia
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        7. Malaysia
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By End User
        8. Singapore
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        9. Philippines
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        10. Vietnam
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        11. Rest of APAC
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
  8. Latin America Perinatal Infections Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
      6. By Country
        1. Brazil
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        2. Mexico
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        3. Argentina
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        4. Peru
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        5. Rest of LATAM
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
  9. Middle East & Africa Perinatal Infections Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Infection
      2. By Diagnosis
      3. By Treatment
      4. By Route of Administration
      5. By End User
      6. By Country
        1. Saudi Arabia
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        2. UAE
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        3. Qatar
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        4. Kuwait
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        5. South Africa
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        6. Nigeria
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        7. Algeria
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
        8. Rest of MEA
          1. By Infection
          2. By Diagnosis
          3. By Treatment
          4. By Route of Administration
          5. By End User
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Perinatal Infections Company Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Perinatal Infections Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Merck KGaA
    2. Beckman Coulter Inc.
    3. BIOMERIEUX
    4. Bio-Rad Laboratories, Inc
    5. Danaher
    6. Hologic Inc.
    7. Gilead Sciences, Inc.
    8. Emcure Pharmaceuticals Limited.
    9. Cipla Inc.
    10. Hetero
    11. Bausch Health Companies Inc.
    12. Johnson & Johnson Private Limited
    13. Mylan N.V.
    14. Teva Pharmaceutical Industries Ltd.
    15. Sanofi
    16. Novartis AG
    17. Sun Pharmaceutical Industries Ltd.
    18. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       Global Perinatal Infections Segmentation

Figure 2       Global Perinatal Infections Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 6       Global Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 7       Global Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 8       Global Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 9       Global Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 10     Global Perinatal Infections Market Share, By Region, By Value, 2019–2029

Figure 11     North America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 12     North America Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 13     North America Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 14     North America Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 15     North America Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 16     North America Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 17     North America Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 18     United States Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 19     United States Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 20     United States Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 21     United States Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 22     United States Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 23     United States Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 24     Canada Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 25     Canada Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 26     Canada Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 27     Canada Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 28     Canada Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 29     Canada Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 30     Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 31     Europe Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 32     Europe Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 33     Europe Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 34     Europe Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 35     Europe Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 36     Europe Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 37     Germany Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 38     Germany Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 39     Germany Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 40     Germany Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 41     Germany Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 42     Germany Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 43     United Kingdom Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 44     United Kingdom Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 45     United Kingdom Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 46     United Kingdom Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 47     United Kingdom Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 48     United Kingdom Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 49     Italy Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 50     Italy Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 51     Italy Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 52     Italy Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 53     Italy Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 54     Italy Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 55     France Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 56     France Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 57     France Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 58     France Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 59     France Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 60     France Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 61     Spain Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 62     Spain Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 63     Spain Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 64     Spain Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 65     Spain Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 66     Spain Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 67     The Netherlands Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 68     The Netherlands Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 69     The Netherlands Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 70     The Netherlands Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 71     The Netherlands Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 72     The Netherlands Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 73     Rest of Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 74     Rest of Europe Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 75     Rest of Europe Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 76     Rest of Europe Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 77     Rest of Europe Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 78     Rest of Europe Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 79     Asia-Pacific Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 80     Asia-Pacific Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 81     Asia-Pacific Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 82     Asia-Pacific Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 83     Asia-Pacific Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 84     Asia-Pacific Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 85     Asia-Pacific Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 86     China Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 87     China Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 88     China Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 89     China Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 90     China Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 91     China Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 92     India Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 93     India Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 94     India Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 95     India Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 96     India Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 97     India Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 98     Japan Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 99     Japan Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 100   Japan Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 101   Japan Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 102   Japan Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 103   Japan Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 104   South Korea Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 105   South Korea Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 106   South Korea Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 107   South Korea Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 108   South Korea Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 109   South Korea Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 110   Australia & New Zealand Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 111   Australia & New Zealand Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 112   Australia & New Zealand Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 113   Australia & New Zealand Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 114   Australia & New Zealand Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 115   Australia & New Zealand Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 116   Indonesia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 117   Indonesia Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 118   Indonesia Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 119   Indonesia Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 120   Indonesia Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 121   Indonesia Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 122   Malaysia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 123   Malaysia Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 124   Malaysia Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 125   Malaysia Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 126   Malaysia Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 127   Malaysia Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 128   Singapore Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 129   Singapore Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 130   Singapore Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 131   Singapore Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 132   Singapore Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 133   Singapore Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 134   Philippines Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 135   Philippines Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 136   Philippines Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 137   Philippines Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 138   Philippines Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 139   Philippines Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 140   Vietnam Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 141   Vietnam Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 142   Vietnam Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 143   Vietnam Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 144   Vietnam Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 145   Vietnam Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 146   Rest of APAC Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 147   Rest of APAC Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 148   Rest of APAC Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 149   Rest of APAC Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 150   Rest of APAC Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 151   Rest of APAC Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 152   Latin America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 153   Latin America Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 154   Latin America Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 155   Latin America Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 156   Latin America Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 157   Latin America Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 158   Latin America Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 159   Brazil Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 160   Brazil Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 161   Brazil Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 162   Brazil Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 163   Brazil Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 164   Brazil Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 165   Mexico Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 166   Mexico Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 167   Mexico Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 168   Mexico Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 169   Mexico Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 170   Mexico Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 171   Argentina Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 172   Argentina Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 173   Argentina Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 174   Argentina Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 175   Argentina Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 176   Argentina Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 177   Peru Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 178   Peru Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 179   Peru Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 180   Peru Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 181   Peru Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 182   Peru Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 183   Rest of LATAM Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 184   Rest of LATAM Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 185   Rest of LATAM Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 186   Rest of LATAM Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 187   Rest of LATAM Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 188   Rest of LATAM Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 189   Middle East & Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 190   Middle East & Africa Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 191   Middle East & Africa Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 192   Middle East & Africa Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 193   Middle East & Africa Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 194   Middle East & Africa Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 195   Middle East & Africa Perinatal Infections Market Share, By Country, By Value, 2019–2029

Figure 196   Saudi Arabia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 197   Saudi Arabia Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 198   Saudi Arabia Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 199   Saudi Arabia Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 200   Saudi Arabia Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 201   Saudi Arabia Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 202   UAE Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 203   UAE Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 204   UAE Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 205   UAE Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 206   UAE Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 207   UAE Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 208   Qatar Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 209   Qatar Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 210   Qatar Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 211   Qatar Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 212   Qatar Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 213   Qatar Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 214   Kuwait Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 215   Kuwait Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 216   Kuwait Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 217   Kuwait Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 218   Kuwait Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 219   Kuwait Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 220   South Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 221   South Africa Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 222   South Africa Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 223   South Africa Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 224   South Africa Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 225   South Africa Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 226   Nigeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 227   Nigeria Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 228   Nigeria Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 229   Nigeria Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 230   Nigeria Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 231   Nigeria Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 232   Algeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 233   Algeria Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 234   Algeria Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 235   Algeria Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 236   Algeria Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 237   Algeria Perinatal Infections Market Share, By End User, By Value, 2019–2029

Figure 238   Rest of MEA Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Figure 239   Rest of MEA Perinatal Infections Market Share, By Infection, By Value, 2019–2029

Figure 240   Rest of MEA Perinatal Infections Market Share, By Diagnosis, By Value, 2019–2029

Figure 241   Rest of MEA Perinatal Infections Market Share, By Treatment, By Value, 2019–2029

Figure 242   Rest of MEA Perinatal Infections Market Share, By Route of Administration, By Value, 2019–2029

Figure 243   Rest of MEA Perinatal Infections Market Share, By End User, By Value, 2019–2029

 

List of Tables

 

Table 1        Global Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 2        Global Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 3        Global Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 4        Global Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 5        Global Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 6        Global Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 7        Global Perinatal Infections Market Size, By Region, By Value, 2019–2029

Table 8        North America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 9        North America Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 10      North America Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 11      North America Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 12      North America Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 13      North America Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 14      North America Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 15      United States Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 16      United States Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 17      United States Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 18      United States Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 19      United States Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 20      United States Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 21      Canada Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 22      Canada Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 23      Canada Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 24      Canada Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 25      Canada Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 26      Canada Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 27      Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 28      Europe Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 29      Europe Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 30      Europe Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 31      Europe Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 32      Europe Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 33      Europe Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 34      Germany Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 35      Germany Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 36      Germany Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 37      Germany Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 38      Germany Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 39      Germany Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 40      United Kingdom Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 41      United Kingdom Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 42      United Kingdom Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 43      United Kingdom Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 44      United Kingdom Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 45      United Kingdom Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 46      Italy Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 47      Italy Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 48      Italy Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 49      Italy Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 50      Italy Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 51      Italy Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 52      France Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 53      France Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 54      France Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 55      France Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 56      France Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 57      France Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 58      Spain Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 59      Spain Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 60      Spain Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 61      Spain Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 62      Spain Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 63      Spain Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 64      The Netherlands Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 65      The Netherlands Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 66      The Netherlands Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 67      The Netherlands Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 68      The Netherlands Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 69      The Netherlands Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 70      Rest of Europe Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 71      Rest of Europe Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 72      Rest of Europe Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 73      Rest of Europe Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 74      Rest of Europe Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 75      Rest of Europe Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 76      Asia-Pacific Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 77      Asia-Pacific Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 78      Asia-Pacific Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 79      Asia-Pacific Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 80      Asia-Pacific Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 81      Asia-Pacific Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 82      Asia-Pacific Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 83      China Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 84      China Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 85      China Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 86      China Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 87      China Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 88      China Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 89      India Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 90      India Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 91      India Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 92      India Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 93      India Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 94      India Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 95      Japan Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 96      Japan Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 97      Japan Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 98      Japan Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 99      Japan Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 100    Japan Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 101    South Korea Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 102    South Korea Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 103    South Korea Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 104    South Korea Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 105    South Korea Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 106    South Korea Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 107    Australia & New Zealand Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 108    Australia & New Zealand Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 109    Australia & New Zealand Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 110    Australia & New Zealand Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 111    Australia & New Zealand Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 112    Australia & New Zealand Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 113    Indonesia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 114    Indonesia Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 115    Indonesia Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 116    Indonesia Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 117    Indonesia Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 118    Indonesia Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 119    Malaysia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 120    Malaysia Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 121    Malaysia Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 122    Malaysia Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 123    Malaysia Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 124    Malaysia Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 125    Singapore Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 126    Singapore Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 127    Singapore Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 128    Singapore Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 129    Singapore Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 130    Singapore Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 131    Philippines Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 132    Philippines Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 133    Philippines Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 134    Philippines Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 135    Philippines Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 136    Philippines Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 137    Vietnam Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 138    Vietnam Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 139    Vietnam Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 140    Vietnam Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 141    Vietnam Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 142    Vietnam Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 143    Rest of APAC Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 144    Rest of APAC Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 145    Rest of APAC Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 146    Rest of APAC Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 147    Rest of APAC Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 148    Rest of APAC Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 149    Latin America Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 150    Latin America Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 151    Latin America Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 152    Latin America Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 153    Latin America Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 154    Latin America Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 155    Latin America Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 156    Brazil Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 157    Brazil Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 158    Brazil Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 159    Brazil Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 160    Brazil Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 161    Brazil Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 162    Mexico Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 163    Mexico Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 164    Mexico Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 165    Mexico Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 166    Mexico Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 167    Mexico Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 168    Argentina Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 169    Argentina Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 170    Argentina Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 171    Argentina Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 172    Argentina Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 173    Argentina Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 174    Peru Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 175    Peru Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 176    Peru Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 177    Peru Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 178    Peru Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 179    Peru Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 180    Rest of LATAM Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 181    Rest of LATAM Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 182    Rest of LATAM Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 183    Rest of LATAM Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 184    Rest of LATAM Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 185    Rest of LATAM Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 186    Middle East & Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 187    Middle East & Africa Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 188    Middle East & Africa Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 189    Middle East & Africa Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 190    Middle East & Africa Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 191    Middle East & Africa Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 192    Middle East & Africa Perinatal Infections Market Size, By Country, By Value, 2019–2029

Table 193    Saudi Arabia Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 194    Saudi Arabia Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 195    Saudi Arabia Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 196    Saudi Arabia Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 197    Saudi Arabia Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 198    Saudi Arabia Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 199    UAE Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 200    UAE Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 201    UAE Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 202    UAE Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 203    UAE Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 204    UAE Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 205    Qatar Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 206    Qatar Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 207    Qatar Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 208    Qatar Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 209    Qatar Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 210    Qatar Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 211    Kuwait Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 212    Kuwait Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 213    Kuwait Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 214    Kuwait Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 215    Kuwait Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 216    Kuwait Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 217    South Africa Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 218    South Africa Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 219    South Africa Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 220    South Africa Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 221    South Africa Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 222    South Africa Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 223    Nigeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 224    Nigeria Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 225    Nigeria Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 226    Nigeria Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 227    Nigeria Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 228    Nigeria Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 229    Algeria Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 230    Algeria Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 231    Algeria Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 232    Algeria Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 233    Algeria Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 234    Algeria Perinatal Infections Market Size, By End User, By Value, 2019–2029

Table 235    Rest of MEA Perinatal Infections Market Size, By Value (USD Million), 2019–2029

Table 236    Rest of MEA Perinatal Infections Market Size, By Infection, By Value, 2019–2029

Table 237    Rest of MEA Perinatal Infections Market Size, By Diagnosis, By Value, 2019–2029

Table 238    Rest of MEA Perinatal Infections Market Size, By Treatment, By Value, 2019–2029

Table 239    Rest of MEA Perinatal Infections Market Size, By Route of Administration, By Value, 2019–2029

Table 240    Rest of MEA Perinatal Infections Market Share, By End User, By Value, 2019–2029

Table 241    ECOM Agroindustrial Corporation Ltd Company Overview

Table 242    ECOM Agroindustrial Corporation Ltd Financial Overview

Table 243    Merck KGaA Company Overview

Table 244    Merck KGaA Financial Overview

Table 245    Beckman Coulter Inc. Company Overview

Table 246    Beckman Coulter Inc. Financial Overview

Table 247    BIOMERIEUX Company Overview

Table 248    BIOMERIEUX Financial Overview

Table 249    Bio-Rad Laboratories, Inc Company Overview

Table 250    Bio-Rad Laboratories, Inc Financial Overview

Table 251    Danaher Company Overview

Table 252    Danaher Financial Overview

Table 253    Hologic Inc. Company Overview

Table 254    Hologic Inc. Financial Overview

Table 255    Gilead Sciences, Inc. Company Overview

Table 256    Gilead Sciences, Inc. Financial Overview

Table 257    Emcure Pharmaceuticals Limited. Company Overview

Table 258    Emcure Pharmaceuticals Limited. Financial Overview

Table 259    Cipla Inc. Company Overview

Table 260    Cipla Inc. Financial Overview

Table 261    Hetero Company Overview

Table 262    Hetero Financial Overview

Table 263    Bausch Health Companies Inc. Company Overview

Table 264    Bausch Health Companies Inc. Financial Overview

Table 265    Johnson & Johnson Private Limited Company Overview

Table 266    Johnson & Johnson Private Limited Financial Overview

Table 267    Mylan N.V. Company Overview

Table 268    Mylan N.V. Financial Overview

Table 269    Teva Pharmaceutical Industries Ltd. Company Overview

Table 270    Teva Pharmaceutical Industries Ltd. Financial Overview

Table 271    Sanofi Company Overview

Table 272    Sanofi Financial Overview

Table 273    Novartis AG Company Overview

Table 274    Novartis AG Financial Overview

Table 275    Sun Pharmaceutical Industries Ltd. Company Overview

Table 276    Sun Pharmaceutical Industries Ltd. Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Asia Pacific is expected to grow at the fastest rate in Global Perinatal Infections Market during the forecast period between 2023 and 2029.
Ans: Major factors driving the growth of Global Perinatal Infections Market include increased cases of HIV and increasing incidence of perinatal infections.
Ans: Global Perinatal Infections market is expected to grow at a CAGR of 7.30% during the forecast period between 2023 and 2029.
Ans: Key players in Global Perinatal Infections Market include Merck KGaA, Beckman Coulter Inc., BIOMERIEUX, Bio-Rad Laboratories, Inc, Danaher, Hologic Inc., Gilead Sciences, Inc., Emcure Pharmaceuticals Limited., Cipla Inc., Hetero, Bausch Health Companies Inc., Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Novartis AG, and Sun Pharmaceutical Industries Ltd.
Ans: The hospitals segment held the highest Market share in the Global Perinatal Infections Market by end user. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1732286189)
}